Matches in Wikidata for { <http://www.wikidata.org/entity/Q105493236> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q105493236 description "clinical trial" @default.
- Q105493236 description "ensayo clínico" @default.
- Q105493236 description "ensayu clínicu" @default.
- Q105493236 description "klinisch onderzoek" @default.
- Q105493236 description "клінічне випробування" @default.
- Q105493236 description "临床试验" @default.
- Q105493236 name "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 name "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 type Item @default.
- Q105493236 label "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 label "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 prefLabel "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 prefLabel "A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 P1050 Q105493236-4328BED9-2AE9-45A0-AEEB-D2F453BD2735 @default.
- Q105493236 P1132 Q105493236-9E540012-0089-43CC-877E-65DCBE376230 @default.
- Q105493236 P1476 Q105493236-6823A693-C77A-42BE-ADFD-FDC624093BD7 @default.
- Q105493236 P2899 Q105493236-3E4DE6AF-2B6F-4AF6-BA65-18C2DE13082E @default.
- Q105493236 P3098 Q105493236-0C5931A8-10BD-4031-9BE4-A9B8C4B57066 @default.
- Q105493236 P31 Q105493236-005EDD9A-5CC3-4F61-95A9-6A51BE74D9AA @default.
- Q105493236 P4844 Q105493236-36111113-CBDF-4BE9-9055-4BCF0A9A5032 @default.
- Q105493236 P4844 Q105493236-4BD5AD68-ED42-4C1C-B961-E84C6CD30291 @default.
- Q105493236 P580 Q105493236-DF6B293B-4198-4FBB-A825-9041A2584380 @default.
- Q105493236 P582 Q105493236-3ED184C4-9B42-4BA3-BD2C-65D6F5E26DA9 @default.
- Q105493236 P6099 Q105493236-4BD578A4-F7DA-4814-9456-EA6790B29F71 @default.
- Q105493236 P8005 Q105493236-A2B2D505-AEDC-4A61-91C2-2257E732C227 @default.
- Q105493236 P8363 Q105493236-C905EFA3-F10C-40F3-86F5-3F5D94D3D738 @default.
- Q105493236 P859 Q105493236-94A7296F-29CC-4C0B-9CFE-82E9702FE806 @default.
- Q105493236 P1050 Q33525 @default.
- Q105493236 P1132 "+100" @default.
- Q105493236 P1476 "A Phase IIIb, Single Arm, Multicenter Study of Atezolizumab in Combination With Bevacizumab to Investigate Safety and Efficacy in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy" @default.
- Q105493236 P2899 "+18" @default.
- Q105493236 P3098 "NCT04732286" @default.
- Q105493236 P31 Q30612 @default.
- Q105493236 P4844 Q20707748 @default.
- Q105493236 P4844 Q413299 @default.
- Q105493236 P580 "2021-02-10T00:00:00Z" @default.
- Q105493236 P582 "2022-12-31T00:00:00Z" @default.
- Q105493236 P6099 Q42824827 @default.
- Q105493236 P8005 Q76649614 @default.
- Q105493236 P8363 Q78089383 @default.
- Q105493236 P859 Q212646 @default.